Respiratory chain complex i is a mitochondrial tumor suppressor of oncocytic tumors

Frontiers in Bioscience - Elite

Volumn 3 E, Issue 1, 2011, Pages 315-325

  Zimmermann, Franz A ^a   Mayr, Johannes A ^a   Feichtinger, Rene ^a   Neureiter, Daniel ^b   Lechner, Roman ^a   Koegler, Christian ^c   Ratschek, Manfred ^c   Rusmir, Husic ^c   Sargsyan, Karine ^c   Sperl, Wolfgang ^a   Kofler, Barbara ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b St Johanns Spital   (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Mitochondria; Mitochondrial DNA; Oncocytic Tumors; Respiratory Chain; Respiratory Chain Complex I; Tumor Suppressor; Warburg Effect

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; CYTOCHROME B; CYTOCHROME C OXIDASE; HYPOXIA INDUCIBLE FACTOR 1; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; NUCLEAR RESPIRATORY FACTOR 1; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RADIOACTIVE IODINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TUMOR SUPPRESSOR PROTEIN;

ADRENAL TUMOR; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RADIOTHERAPY; COMPLEX I DEFICIENCY; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME HISTOCHEMISTRY; EYELID TUMOR; FOLLICULAR CARCINOMA; GENE SEQUENCE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; KIDNEY TUMOR; METASTASIS; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MUTATION RATE; NEUROBLASTOMA; NONSENSE MUTATION; NULL CELL ADENOMA; ONCOCYTOMA; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PAPILLARY CARCINOMA; PARATHYROID ADENOMA; PHENOTYPE; POINT MUTATION; PROMOTER REGION; RESPIRATORY CHAIN; SALIVARY GLAND TUMOR; SEQUENCE ANALYSIS; SOMATIC MUTATION; STOP CODON; THYROID CARCINOMA; THYROID PARAFOLLICULAR CELL; TREATMENT RESPONSE; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING; DNA SEQUENCE; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW;

ADENOMA, OXYPHILIC; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX I; ENERGY METABOLISM; HUMANS; IMMUNOHISTOCHEMISTRY; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 79957851372     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. O. Warburg: On the origin of cancer cells. Science, 123(3191), 309-14 (1956)
2. B. E. Baysal, R. E. Ferrell, J. E. Willett-Brozick, E. C. Lawrence, D. Myssiorek, A. Bosch, A. van der Mey, P. E. Taschner, W. S. Rubinstein, E. N. Myers, C. W. Richard, 3rd, C. J. Cornelisse, P. Devilee and B. Devlin: Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science, 287(5454), 848-51 (2000) (Pubitemid 30084326)
3. D. Astuti, F. Latif, A. Dallol, P. L. Dahia, F. Douglas, E. George, F. Skoldberg, E. S. Husebye, C. Eng and E. R. Maher: Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet, 69(1), 49-54 (2001) (Pubitemid 32614017)
4. I. P. Tomlinson, N. A. Alam, A. J. Rowan, E. Barclay, E. E. Jaeger, D. Kelsell, I. Leigh, P. Gorman, H. Lamlum, S. Rahman, R. R. Roylance, S. Olpin, S. Bevan, K. Barker, N. Hearle, R. S. Houlston, M. Kiuru, R. Lehtonen, A. Karhu, S. Vilkki, P. Laiho, C. Eklund, O. Vierimaa, K. Aittomaki, M. Hietala, P. Sistonen, A. Paetau, R. Salovaara, R. Herva, V. Launonen and L. A. Aaltonen: Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet, 30(4), 406-10 (2002)
5. L. G. Carvajal-Carmona, N. A. Alam, P. J. Pollard, A. M. Jones, E. Barclay, N. Wortham, M. Pignatelli, A. Freeman, S. Pomplun, I. Ellis, R. Poulsom, M. A. El- Bahrawy, D. M. Berney and I. P. Tomlinson: Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations. J Clin Endocrinol Metab, 91(8), 3071- 5 (2006)
6. F. E. Bleeker, S. Lamba, S. Leenstra, D. Troost, T. Hulsebos, W. P. Vandertop, M. Frattini, F. Molinari, M. Knowles, A. Cerrato, M. Rodolfo, A. Scarpa, L. Felicioni, F. Buttitta, S. Malatesta, A. Marchetti and A. Bardelli: IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat, 30(1), 7-11 (2009)
7. D. W. Parsons, S. Jones, X. Zhang, J. C. Lin, R. J. Leary, P. Angenendt, P. Mankoo, H. Carter, I. M. Siu, G. L. Gallia, A. Olivi, R. McLendon, B. A. Rasheed, S. Keir, T. Nikolskaya, Y. Nikolsky, D. A. Busam, H. Tekleab, L. A. Diaz, Jr., J. Hartigan, D. R. Smith, R. L. Strausberg, S. K. Marie, S. M. Shinjo, H. Yan, G. J. Riggins, D. D. Bigner, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V. E. Velculescu and K. W. Kinzler: An integrated genomic analysis of human glioblastoma multiforme. Science, 321(5897), 1807-12 (2008)
8. H. Yan, D. W. Parsons, G. Jin, R. McLendon, B. A. Rasheed, W. Yuan, I. Kos, I. Batinic-Haberle, S. Jones, G. J. Riggins, H. Friedman, A. Friedman, D. Reardon, J. Herndon, K. W. Kinzler, V. E. Velculescu, B. Vogelstein and D. D. Bigner: IDH1 and IDH2 mutations in gliomas. N Engl J Med, 360(8), 765-73 (2009)
9. E. Gottlieb and I. P. Tomlinson: Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer, 5(11), 857-66 (2005) (Pubitemid 41746030)
10. C. B. Thompson: Metabolic enzymes as oncogenes or tumor suppressors. N Engl J Med, 360(8), 813-5 (2009)
11. C. Santos, M. Martinez, M. Lima, Y. J. Hao, N. Simoes and R. Montiel: Mitochondrial DNA mutations in cancer: a review. Curr Top Med Chem, 8(15), 1351-66 (2008)
12. V. Maximo, J. Lima, P. Soares and M. Sobrinho- Simoes: Mitochondria and cancer. Virchows Arch, 454(5), 481-95 (2009)
13. P. Parrella, Y. Xiao, M. Fliss, M. Sanchez-Cespedes, P. Mazzarelli, M. Rinaldi, T. Nicol, E. Gabrielson, C. Cuomo, D. Cohen, S. Pandit, M. Spencer, C. Rabitti, V. M. Fazio and D. Sidransky: Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res, 61(20), 7623-6 (2001) (Pubitemid 32995057)
14. A. M. Czarnecka, W. Kukwa, T. Krawczyk, A. Scinska, A. Kukwa and F. Cappello: Mitochondrial DNA mutations in cancer - from bench to bedside. Front Biosci, 15437-60 (2010)
15. A. M. Czarnecka, J. S. Czarnecki, W. Kukwa, F. Cappello, A. Scinska and A. Kukwa: Molecular oncology focus - Is carcinogenesis a 'mitochondriopathy'? J Biomed Sci, 17(1), 31 (2010)
16. H. A. Coller, K. Khrapko, N. D. Bodyak, E. Nekhaeva, P. Herrero-Jimenez and W. G. Thilly: High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet, 28(2), 147-50 (2001) (Pubitemid 32538059)
17. H. A. Coller, N. D. Bodyak and K. Khrapko: Frequent intracellular clonal expansions of somatic mtDNA mutations: significance and mechanisms. Ann N Y Acad Sci, 959434-47 (2002)
18. D. Meierhofer, J. A. Mayr, K. Fink, N. Schmeller, B. Kofler and W. Sperl: Mitochondrial DNA mutations in renal cell carcinomas revealed no general impact on energy metabolism. Br J Cancer, 94(2), 268-74 (2006) (Pubitemid 43151546)
19. G. Tallini: Oncocytic tumours. Virchows Arch, 433(1), 5-12 (1998) (Pubitemid 28356470)
20. S. Jalalah, E. Horvath and K. Kovacs: Electron dense mitochondrial inclusions in a pituitary oncocytoma. J Submicrosc Cytol, 17(4), 667-71 (1985)
21. J. D. van der Walt, H. A. Reid, R. A. Risdon and J. H. Shaw: Renal oncocytoma. A review of the literature and report of an unusual multicentric case. Virchows Arch A Pathol Anat Histopathol, 398(3), 291-304 (1983) (Pubitemid 13177669)
22. D. Ebner, G. Rodel, I. Pavenstaedt and O. Haferkamp: Functional and molecular analysis of mitochondria in thyroid oncocytoma. Virchows Arch B Cell Pathol Incl Mol Pathol, 60(2), 139-44 (1991)
23. A. Heddi, H. Faure-Vigny, D. C. Wallace and G. Stepien: Coordinate expression of nuclear and mitochondrial genes involved in energy production in carcinoma and oncocytoma. Biochim Biophys Acta, 1316(3), 203-9 (1996) (Pubitemid 26273705)
24. O. Baris, F. Savagner, V. Nasser, B. Loriod, S. Granjeaud, S. Guyetant, B. Franc, P. Rodien, V. Rohmer, F. Bertucci, D. Birnbaum, Y. Malthiery, P. Reynier and R. Houlgatte: Transcriptional profiling reveals coordinated upregulation of oxidative metabolism genes in thyroid oncocytic tumors. J Clin Endocrinol Metab, 89(2), 994- 1005 (2004) (Pubitemid 38269923)
25. F. Savagner, B. Franc, S. Guyetant, P. Rodien, P. Reynier and Y. Malthiery: Defective mitochondrial ATP synthesis in oxyphilic thyroid tumors. J Clin Endocrinol Metab, 86(10), 4920-5 (2001) (Pubitemid 33020542)
26. D. C. Wallace, X. X. Zheng, M. T. Lott, J. M. Shoffner, J. A. Hodge, R. I. Kelley, C. M. Epstein and L. C. Hopkins: Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell, 55(4), 601-10 (1988)
27. F. A. Zimmermann, J. A. Mayr, D. Neureiter, R. Feichtinger, B. Alinger, N. D. Jones, W. Eder, W. Sperl and B. Kofler: Lack of complex I is associated with oncocytic thyroid tumours. Br J Cancer, 100(9), 1434-7 (2009)
28. W. Thoenes, H. J. Rumpelt and S. Storkel: [Classification of renal cell carcinoma/tumors and their relationship to the nephron-collecting tubules system]. Klin Wochenschr, 68(22), 1102-11 (1990)
29. N. Kuroda, M. Toi, M. Hiroi, T. Shuin and H. Enzan: Review of renal oncocytoma with focus on clinical and pathobiological aspects. Histol Histopathol, 18(3), 935-42 (2003) (Pubitemid 36773237)
30. H. Simonnet, J. Demont, K. Pfeiffer, L. Guenaneche, R. Bouvier, U. Brandt, H. Schagger and C. Godinot: Mitochondrial complex I is deficient in renal oncocytomas. Carcinogenesis, 24(9), 1461-6 (2003) (Pubitemid 37160836)
31. G. Gasparre, E. Hervouet, E. de Laplanche, J. Demont, L. F. Pennisi, M. Colombel, F. Mege-Lechevallier, J. Y. Scoazec, E. Bonora, R. Smeets, J. Smeitink, V. Lazar, J. Lespinasse, S. Giraud, C. Godinot, G. Romeo and H. Simonnet: Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma. Hum Mol Genet, 17(7), 986-95 (2008) (Pubitemid 351426033)
32. J. A. Mayr, D. Meierhofer, F. Zimmermann, R. Feichtinger, C. Kogler, M. Ratschek, N. Schmeller, W. Sperl and B. Kofler: Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma. Clin Cancer Res, 14(8), 2270-5 (2008) (Pubitemid 351551057)
33. M. V. Yusenko, T. Ruppert and G. Kovacs: Analysis of differentially expressed mitochondrial proteins in chromophobe renal cell carcinomas and renal oncocytomas by 2-D gel electrophoresis. Int J Biol Sci, 6(3), 213-24 (2010)
34. R. Acin-Perez, M. P. Bayona-Bafaluy, P. Fernandez- Silva, R. Moreno-Loshuertos, A. Perez-Martos, C. Bruno, C. T. Moraes and J. A. Enriquez: Respiratory complex III is required to maintain complex I in mammalian mitochondria. Mol Cell, 13(6), 805-15 (2004) (Pubitemid 38438476)
35. D. Meierhofer, J. A. Mayr, U. Foetschl, A. Berger, K. Fink, N. Schmeller, G. W. Hacker, C. Hauser-Kronberger, B. Kofler and W. Sperl: Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma. Carcinogenesis, 25(6), 1005-10 (2004) (Pubitemid 38886085)
36. H. Zhang, P. Gao, R. Fukuda, G. Kumar, B. Krishnamachary, K. I. Zeller, C. V. Dang and G. L. Semenza: HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell, 11(5), 407- 20 (2007) (Pubitemid 46670080)
37. R. G. Feichtinger, F. Zimmermann, J. A. Mayr, D. Neureiter, C. Hauser-Kronberger, F. H. Schilling, N. Jones, W. Sperl and B. Kofler: Low aerobic mitochondrial energy metabolism in poorly- or undifferentiated neuroblastoma. BMC Cancer, 10(1):149 (2010)
38. S. Sidhu: Hurthle cell neoplasm of the thyroid gland. ANZ J Surg, 78(3), 115 (2008) (Pubitemid 351207380)
39. M. R. Hanief, L. Igali and D. Grama: Hurthle cell carcinoma: diagnostic and therapeutic implications. World J Surg Oncol, 227 (2004)
40. Y. Kushchayeva, Q. Y. Duh, E. Kebebew and O. H. Clark: Prognostic indications for Hurthle cell cancer. World J Surg, 28(12), 1266-70 (2004) (Pubitemid 40941290)
41. F. Savagner, D. Mirebeau, C. Jacques, S. Guyetant, C. Morgan, B. Franc, P. Reynier and Y. Malthiery: PGC-1- related coactivator and targets are upregulated in thyroid oncocytoma. Biochem Biophys Res Commun, 310(3), 779- 84 (2003) (Pubitemid 37188689)
42. C. Jacques, J. F. Fontaine, B. Franc, D. Mirebeau- Prunier, S. Triau, F. Savagner and Y. Malthiery: Deathassociated protein 3 is overexpressed in human thyroid oncocytic tumours. Br J Cancer, 101(1), 132-8 (2009)
43. V. Maximo, T. Botelho, J. Capela, P. Soares, J. Lima, A. Taveira, T. Amaro, A. P. Barbosa, A. Preto, H. R. Harach, D. Williams and M. Sobrinho-Simoes: Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer, 92(10), 1892-8 (2005) (Pubitemid 40826138)
44. V. Maximo, P. Soares, J. Lima, J. Cameselle-Teijeiro and M. Sobrinho-Simoes: Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. Am J Pathol, 160(5), 1857-65 (2002) (Pubitemid 34525665)
45. G. Gasparre, A. M. Porcelli, E. Bonora, L. F. Pennisi, M. Toller, L. Iommarini, A. Ghelli, M. Moretti, C. M. Betts, G. N. Martinelli, A. R. Ceroni, F. Curcio, V. Carelli, M. Rugolo, G. Tallini and G. Romeo: Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors. Proc Natl Acad Sci U S A, 104(21), 9001-6 (2007) (Pubitemid 47175426)
46. E. Bonora, A. M. Porcelli, G. Gasparre, A. Biondi, A. Ghelli, V. Carelli, A. Baracca, G. Tallini, A. Martinuzzi, G. Lenaz, M. Rugolo and G. Romeo: Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III. Cancer Res, 66(12), 6087-96 (2006)
47. J. Costa-Guda, T. Tokura, S. I. Roth and A. Arnold: Mitochondrial DNA mutations in oxyphilic and chief cell parathyroid adenomas. BMC Endocr Disord, 78 (2007)
48. Y. Goto, S. Horai, T. Matsuoka, Y. Koga, K. Nihei, M. Kobayashi and I. Nonaka: Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology, 42(3 Pt 1), 545-50 (1992)
49. D. K. Banerjee, K. R. Korzec, K. Kim and L. Fanelly: Nasopharyngeal oncocytoma. Otolaryngol Head Neck Surg, 113(1), 136-7 (1995)
50. F. W. Albers, C. A. Cuvelier, M. T. Renders and P. B. van Cauwenberge: Oncocytoma of the nasopharynx. Rhinology, 31(1), 41-3 (1993) (Pubitemid 23158592)
51. G. Gasparre, L. Iommarini, A. M. Porcelli, M. Lang, G. G. Ferri, I. Kurelac, R. Zuntini, E. Mariani, L. F. Pennisi, E. Pasquini, G. Pasquinelli, A. Ghelli, E. Bonora, C. Ceccarelli, M. Rugolo, N. Salfi, G. Romeo and V. Carelli: An inherited mitochondrial DNA disruptive mutation shifts to homoplasmy in oncocytic tumor cells. Hum Mutat, 30(3), 391-6 (2009)
52. T. D. Shellenberger, M. D. Williams, G. L. Clayman and A. J. Kumar: Parotid gland oncocytosis: CT findings with histopathologic correlation. AJNR Am J Neuroradiol, 29(4), 734-6 (2008) (Pubitemid 351571557)
53. L. Ghandur-Mnaymneh: Multinodular oncocytoma of the parotid gland: a benign lesion simulating malignancy. Hum Pathol, 15(5), 485-6 (1984) (Pubitemid 15163013)
54. H. Sasano, T. Suzuki, T. Sano, T. Kameya, N. Sasano and H. Nagura: Adrenocortical oncocytoma. A true nonfunctioning adrenocortical tumor. Am J Surg Pathol, 15(10), 949-56 (1991)
55. G. T. Tahar, K. N. Nejib, S. S. Sadok and L. M. Rachid: Adrenocortical oncocytoma: a case report and review of literature. J Pediatr Surg, 43(5), E1-3 (2008) (Pubitemid 351657558)
56. Z. W. Baloch and V. A. LiVolsi: Oncocytic lesions of the neuroendocrine system. Semin Diagn Pathol, 16(2), 190-9 (1999) (Pubitemid 29357975)
57. F. Giangaspero and G. Cenacchi: Oncocytic and granular cell neoplasms of the central nervous system and pituitary gland. Semin Diagn Pathol, 16(2), 91-7 (1999) (Pubitemid 29357966)
58. H. Nishioka, H. Ito, A. Hirano, N. Shibata and M. Kobayashi: Immunocytochemical study of pituitary oncocytic adenomas. Acta Neuropathol, 94(1), 42-7 (1997) (Pubitemid 27289101)
59. J. R. Cameron and C. W. Barras: Oncocytoma of the eyelid. Acta Ophthalmol Scand, 83(1), 125 (2005)
60. S. Damiani, V. Eusebi, L. Losi, T. D'Adda and J. Rosai: Oncocytic carcinoma (malignant oncocytoma) of the breast. Am J Surg Pathol, 22(2), 221-30 (1998) (Pubitemid 28113384)
61. M. Huntrakoon: Oncocytic carcinoma of the pancreas. Cancer, 51(2), 332-6 (1983) (Pubitemid 13179480)
62. P. R. Millard and H. M. Bishop: Oncocytoma of the stomach: a case report. Histopathology, 8(6), 1053-8 (1984) (Pubitemid 15159735)
63. A. Caldarella, A. M. Buccoliero, M. Marini, A. Taddei, P. Mennonna and G. L. Taddei: Oncocytic meningioma: a case report. Pathol Res Pract, 198(2), 109-13 (2002) (Pubitemid 34232832)
64. K. Ishikawa, K. Takenaga, M. Akimoto, N. Koshikawa, A. Yamaguchi, H. Imanishi, K. Nakada, Y. Honma and J. Hayashi: ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science, 320(5876), 661-4 (2008) (Pubitemid 351928347)
65. J. E. Ricci, C. Munoz-Pinedo, P. Fitzgerald, B. Bailly- Maitre, G. A. Perkins, N. Yadava, I. E. Scheffler, M. H. Ellisman and D. R. Green: Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell, 117(6), 773-86 (2004) (Pubitemid 38748893)
66. G. Huang, Y. Chen, H. Lu and X. Cao: Coupling mitochondrial respiratory chain to cell death: an essential role of mitochondrial complex I in the interferon-beta and retinoic acid-induced cancer cell death. Cell Death Differ, 14(2), 327-37 (2007) (Pubitemid 46092235)
67. D. Martinvalet, D. M. Dykxhoorn, R. Ferrini and J. Lieberman: Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-independent cell death. Cell, 133(4), 681-92 (2008) (Pubitemid 351636303)
68. S. J. Lord, R. V. Rajotte, G. S. Korbutt and R. C. Bleackley: Granzyme B: a natural born killer. Immunol Rev, 19331-8 (2003)
69. M. G. Vander Heiden, L. C. Cantley and C. B. Thompson: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 324(5930), 1029-33 (2009)
70. R. G. Jones and C. B. Thompson: Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev, 23(5), 537-48 (2009)
71. M. W. Nijsten and G. M. van Dam: Hypothesis: using the Warburg effect against cancer by reducing glucose and providing lactate. Med Hypotheses, 73(1), 48-51 (2009)
72. D. Pathania, M. Millard and N. Neamati: Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. Adv Drug Deliv Rev, 61(14), 1250-75 (2009)
73. B. T. Seyfried, M. Kiebish, J. Marsh and P. Mukherjee: Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet. J Cancer Res Ther, 5 Suppl 1S7-15 (2009)